Artificial intelligence (AI) is booming.
Among various AI approaches,
generative models have received much attention in recent years. Inspired
by these successes, researchers are now applying generative model
techniques to de novo drug design, which has been considered as the
“holy grail” of drug discovery. In this Perspective,
we first focus on describing models such as recurrent neural network,
autoencoder, generative adversarial network, transformer, and hybrid
models with reinforcement learning. Next, we summarize the applications
of generative models to drug design, including generating various
compounds to expand the compound library and designing compounds with
specific properties, and we also list a few publicly available molecular
design tools based on generative models which can be used directly
to generate molecules. In addition, we also introduce current benchmarks
and metrics frequently used for generative models. Finally, we discuss
the challenges and prospects of using generative models to aid drug
design.